COVID-19 Vaccine

FDA Approval for COVID-19 Vaccine

Renal Associates of West Michigan, P.C. is recommending all patients to receive a COVID-19 vaccine.  Please see the below regarding the FDA’s approval.  If you are unsure about receiving the vaccine, please contact the office and discuss your concerns with your nurse at (616) 752-6235.

August 23, 2021, the FDA approved the first COVID-19 vaccine.   The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older.

Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into – nor does it alter – an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart.


For the latest information on the COVID-19 vaccine and kidney disease, please see the following link from the National Kidney Foundation of Michigan.

If you have a specific question related to your health, please feel free to contact your Physician either through the patient portal or by calling us at 616-752-6235, press option 6 for the Nurse line, and then press the option for your specific Physician’s Nurse.

Share on facebook
Share on twitter
Share on pinterest